We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

6 hedge funds and large institutions have $6.18M invested in Eterna Therapeutics in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $4.47M → $6.18M (+$1.71M)

14% less funds holding

Funds holding: 7 → 6 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
6
Holders Change
-1
Holders Change %
-14.29%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$338K

Top Sellers

Rank Fund Capital Flow
1
PCM
Perritt Capital Management
Illinois
-$164K
2
GPCM
Granite Point Capital Management
Massachusetts
-$160K
3
VKH
Virtu KCG Holdings
New York
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$2.92M – – –
EAM
2
Eagle Asset Management
Florida
$1.54M – – –
MHP
3
Manatuck Hill Partners
Connecticut
$628K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$401K +$338K +2 New
Renaissance Technologies
5
Renaissance Technologies
New York
$268K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$210K – – –
State of New Jersey Common Pension Fund D
7
State of New Jersey Common Pension Fund D
New Jersey
$71K – – –
BIT
8
BlackRock Institutional Trust
California
$44K – – –
Goldman Sachs
9
Goldman Sachs
New York
$34K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$22K – – –
OC
11
Oppenheimer & Co
New York
$18K – – –
Northern Trust
12
Northern Trust
Illinois
$10K – – –
UBS Group
13
UBS Group
Switzerland
$10K – – –
Morgan Stanley
14
Morgan Stanley
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
15
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2 – – –
GPCM
16
Granite Point Capital Management
Massachusetts
– -$160K -1 Closed
PCM
17
Perritt Capital Management
Illinois
– -$164K -1 Closed
VKH
18
Virtu KCG Holdings
New York
– -$35K – –

ERNA Hedge Fund Activity: Q3 2015 in Review

6 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q3 2015, worth a combined $6.18M — up 38% from $4.47M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ERNA and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Geode Capital Management, opening a new position worth an estimated $338K. The largest seller was Perritt Capital Management, exiting entirely with an estimated $164K sold.

  • 6 institutional investors held Eterna Therapeutics (ERNA) as of Q3 2015, down from 7 in Q2 2015.
  • Funds reported $6.18M of Eterna Therapeutics stock for Q3 2015, up 38% quarter-over-quarter.
  • 1 fund opened new Eterna Therapeutics positions in Q3 2015 and 2 closed out, a net change of -1 holder.
  • The largest Eterna Therapeutics buyer in Q3 2015 was Geode Capital Management, an estimated $338K added.
  • The largest Eterna Therapeutics seller in Q3 2015 was Perritt Capital Management, an estimated $164K sold.

Based on aggregated 13F filings for Q3 2015.